Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Synopsys, Inc. Stock (SNPS) Opinions on Nvidia Investment and Legal Challenges

None

Nvidia Investment Buzz: Recent chatter on social media has been dominated by Nvidia's $2 billion investment in Synopsys, Inc., highlighting a major strategic partnership. Many users are excited about the potential for this deal to accelerate AI and chip design innovation. The collaboration is seen as a game-changer by some, with discussions focusing on long-term growth prospects.

Legal and Market Concerns: Alongside the optimism, there’s notable concern on social media about a class action lawsuit filed against Synopsys, as reported in recent web updates. Some are questioning the impact of these legal challenges on the stock’s momentum. Despite this, others remain bullish, pointing to analyst targets and institutional buying as reasons for confidence.

Note: This discussion summary was generated from an AI condensation of post data.

Synopsys, Inc. Insider Trading Activity

SNPS Insider Trades

Synopsys, Inc. insiders have traded $SNPS stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by insiders over the last 6 months:

  • SUDHINDRA KANKANWADI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 15,873 shares for an estimated $7,837,408.
  • SASSINE GHAZI (PRESIDENT AND CEO) sold 11,366 shares for an estimated $6,694,725
  • SHELAGH GLASER (CFO) has made 0 purchases and 4 sales selling 7,312 shares for an estimated $3,913,745.
  • ROBERT G PAINTER purchased 350 shares for an estimated $148,903

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Synopsys, Inc. Revenue

SNPS Quarterly Revenue

Synopsys, Inc. had revenues of $2.3B in Q4 2025. This is an increase of 37.83% from the same period in the prior year.

You can track SNPS financials on Quiver Quantitative's SNPS stock page.

Synopsys, Inc. Congressional Stock Trading

Members of Congress have traded $SNPS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Synopsys, Inc. Hedge Fund Activity

We have seen 970 institutional investors add shares of Synopsys, Inc. stock to their portfolio, and 459 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • VANGUARD GROUP INC added 3,120,401 shares (+20.7%) to their portfolio in Q3 2025, for an estimated $1,539,574,649
  • MORGAN STANLEY added 2,600,089 shares (+139.5%) to their portfolio in Q3 2025, for an estimated $1,282,857,911
  • BLACKROCK, INC. added 2,371,463 shares (+18.5%) to their portfolio in Q3 2025, for an estimated $1,170,056,129
  • PRICE T ROWE ASSOCIATES INC /MD/ removed 2,001,274 shares (-37.6%) from their portfolio in Q3 2025, for an estimated $987,408,578
  • VICTORY CAPITAL MANAGEMENT INC added 1,990,608 shares (+238.8%) to their portfolio in Q3 2025, for an estimated $982,146,081
  • FMR LLC added 1,868,243 shares (+47.5%) to their portfolio in Q3 2025, for an estimated $921,772,413
  • COATUE MANAGEMENT LLC added 1,809,127 shares (+inf%) to their portfolio in Q3 2025, for an estimated $892,605,170

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Synopsys, Inc. Government Contracts

We have seen $380,206 of award payments to $SNPS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Synopsys, Inc. Analyst Ratings

Wall Street analysts have issued reports on $SNPS in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Rosenblatt issued a "Buy" rating on 12/11/2025
  • B of A Securities issued a "Buy" rating on 12/11/2025
  • Citigroup issued a "Buy" rating on 11/24/2025
  • Exane BNP Paribas issued a "Underperform" rating on 10/02/2025
  • Morgan Stanley issued a "Overweight" rating on 09/11/2025
  • Mizuho issued a "Outperform" rating on 09/11/2025
  • JP Morgan issued a "Overweight" rating on 09/10/2025

To track analyst ratings and price targets for Synopsys, Inc., check out Quiver Quantitative's $SNPS forecast page.

Synopsys, Inc. Price Targets

Multiple analysts have issued price targets for $SNPS recently. We have seen 14 analysts offer price targets for $SNPS in the last 6 months, with a median target of $570.0.

Here are some recent targets:

  • Lee Simpson from Morgan Stanley set a target price of $550.0 on 12/12/2025
  • Jason Celino from Keybanc set a target price of $600.0 on 12/11/2025
  • Charles Shi from Needham set a target price of $580.0 on 12/11/2025
  • Blair Abernethy from Rosenblatt set a target price of $560.0 on 12/11/2025
  • Vivek Arya from B of A Securities set a target price of $560.0 on 12/11/2025
  • Clarke Jeffries from Piper Sandler set a target price of $602.0 on 12/11/2025
  • Harlan Sur from JP Morgan set a target price of $650.0 on 12/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles